Business Combinations and Divestments (Tables)

12 Months Ended

Dec. 31, 2025

Plasma centers acquired from Immunotek

Business Combinations and Divestments

Schedule of detailed information about business combination

	Millions of Euros	Millions of US Dollar
Consideration	268	281
Advance payment	(134)	(140)
Net consideration	134	141
Step-up of net assets adquired1	—	—
Goodwill	268	281
Adjustments from acquisition 2	(27)	(28)
Goodwill, net of adjustments	241	253

¹There is no revaluation of net assets since the fair value of the same does not differ from their carrying value, which was previously recognized in the consolidated financial statements in the context of a joint operation.

²The adjustments resulting from the acquisition relate primarily to the elimination of the net balance payable that the silos maintained with ImmunoTek. Such balances are the accumulated losses from the silos, which are allocated to ImmunoTek in accordance with the terms of the contract.

Group 1 centers and Group 2 centers

Business Combinations and Divestments

Schedule of detailed information about business combination

	Millions of Euros	Millions of US Dollar
Consideration paid	246	266
Step-up of net assets 1	—	—
Goodwill	246	266
Adjustments from the acquisition 2	(10)	(10)
Goodwill, net of adjustments	236	256

¹There is no step-up of net of assets since the fair value and the carrying amount do no differ significantly. Additionally, the net assets were previously recognized in the consolidated financial statements as part of the joint operation.

²The adjustments resulting from the acquisition correspond mainly to the elimination of the net balance payable that the silos maintained with Immunotek. The net amount represents the accumulated losses from the silos, which were allocated to Immunotek in accordance with the terms of the contract (see note 10)